NASDAQ:MCUR - Macrocure Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
$1.51
0.00 (0.00 %)
(As of 01/31/2017)
eye icon Add
Today's Range
$1.51
Now: $1.51
$1.51
50-Day Range N/A
52-Week Range
$0.75
Now: $1.51
$3.20
VolumeN/A
Average Volume98,746 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Leap Therapeutics Ltd, formerly Macrocure Ltd, is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs for the treatment of chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is a combination of living human white blood cells that have been activated to facilitate the healing process and stimulate wound closure. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:MCUR
CUSIPN/A
Phone+972-3-9235556

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MCUR News and Ratings via Email

Sign-up to receive the latest news and ratings for MCUR and its competitors with MarketBeat's FREE daily newsletter.

Macrocure (NASDAQ:MCUR) Frequently Asked Questions

What is Macrocure's stock symbol?

Macrocure trades on the NASDAQ under the ticker symbol "MCUR."

How were Macrocure's earnings last quarter?

Macrocure Ltd (NASDAQ:MCUR) released its quarterly earnings results on Tuesday, November, 17th. The biotechnology company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.04. View Macrocure's Earnings History.

Has Macrocure been receiving favorable news coverage?

Media stories about MCUR stock have trended positive on Tuesday, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Macrocure earned a news impact score of 2.3 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Macrocure.

What other stocks do shareholders of Macrocure own?

What is Macrocure's stock price today?

One share of MCUR stock can currently be purchased for approximately $1.51.

What is Macrocure's official website?

The official website for Macrocure is http://www.macrocure.com/.

How can I contact Macrocure?

Macrocure's mailing address is 25 Sivim Street, PETAH TIKVA, 4959383, Israel. The biotechnology company can be reached via phone at +972-3-9235556.


MarketBeat Community Rating for Macrocure (NASDAQ MCUR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  199
MarketBeat's community ratings are surveys of what our community members think about Macrocure and other stocks. Vote "Outperform" if you believe MCUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel